Study on infusion rate of snake antivenom therapy
Not Applicable
- Conditions
- Snakebites requiring antivenom administration
- Registration Number
- SLCTR/2007/005
- Lead Sponsor
- IRQUE Project
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- 206
Inclusion Criteria
Patients with a possible clinical diagnosis of a snakebite
Exclusion Criteria
* Under 14 years of age * Pregnant ladies * Previous administration of antivenom * Refusal of consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion with severe systemic allergic reactions within 4 hours of commencement of antivenom [within 4 hours of commencement]<br>
- Secondary Outcome Measures
Name Time Method * Proportion with elevated mast cell tryptase * Proportion with elevated antivenom specific IgE * Hospital length of stay * Proportion with mild allergic reactions * Proportion with delayed administration of -further antivenom therapy * Proportion developing serum sickness []<br>